News
ONCO
0.9099
+2.05%
0.0183
Weekly Report: what happened at ONCO last week (0803-0807)?
Weekly Report · 3d ago
Weekly Report: what happened at ONCO last week (0727-0731)?
Weekly Report · 08/03 10:07
Onconetix Secures Major PIPE and Equity Facility Financing
TipRanks · 07/29 21:29
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 07/29 21:06
Weekly Report: what happened at ONCO last week (0720-0724)?
Weekly Report · 07/27 10:11
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 07/24 17:05
Weekly Report: what happened at ONCO last week (0713-0717)?
Weekly Report · 07/20 10:08
Weekly Report: what happened at ONCO last week (0706-0710)?
Weekly Report · 07/13 10:10
Weekly Report: what happened at ONCO last week (0629-0703)?
Weekly Report · 07/06 10:13
Least shorted U.S. small-cap stocks
Seeking Alpha · 07/02 13:55
Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in June 2026
Seeking Alpha · 07/01 14:20
Weekly Report: what happened at ONCO last week (0622-0626)?
Weekly Report · 06/29 10:09
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 06/23 21:05
Weekly Report: what happened at ONCO last week (0615-0619)?
Weekly Report · 06/22 10:17
Oncopeptides Announces First Patient Enrollment In Clinical "Window-Of-Opportunity" Study Evaluating Proprietary Peptide Drug Conjugate Platform In Glioblastoma
Benzinga · 06/17 11:53
Weekly Report: what happened at ONCO last week (0608-0612)?
Weekly Report · 06/15 10:18
Onconetix files to sell 100M shares of common stock for holders
TipRanks · 06/09 10:06
Weekly Report: what happened at ONCO last week (0601-0605)?
Weekly Report · 06/08 10:14
Weekly Report: what happened at ONCO last week (0525-0529)?
Weekly Report · 06/01 10:18
Weekly Report: what happened at ONCO last week (0518-0522)?
Weekly Report · 05/25 10:21
More
Webull provides a variety of real-time ONCO stock news. You can receive the latest news about Onconetix through multiple platforms. This information may help you make smarter investment decisions.
About ONCO
Onconetix, Inc. is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men’s health and oncology. The Company owns Proclarix, an in vitro diagnostic test for prostate cancer approved for sale in the European Union under the In Vitro Diagnostic Regulation. Proclarix is an easy-to-use next generation protein-based blood test that can be done with the same sample as a patient’s regular Prostate-Specific Antigen (PSA) test.